Helen Palmer | Mar 12, 2007
The FDA issued new guidelines today for fresh-cut produce. But the agency's director says the new guidelines aren't exactly the scientific solution to food-borne illness. Helen Palmer reports.
Kai Ryssdal | Mar 12, 2007
Allan Brandt, professor of the history of medicine at Harvard University, talks about his new book, "The Cigarette Century," with Kai Ryssdal.
Kyle James | Mar 12, 2007
A group in Denmark is trying to convince companies that they can increase productivity if they make life easier for late risers. Kyle James reports.
Scott Jagow | Mar 12, 2007
How did McClatchy get that $160 million tax break when it sold the Minneapolis Star-Tribune last week? Turns out it's thanks to a little-used type of merger that's pretty smart.
| Mar 12, 2007
Hurricane futures begin trading on the Merc today. It's a new way for businesses to hedge against hurricane losses, and building it required a new way of classifying the storms.
| Mar 12, 2007
Halliburton announced yesterday that it's moving its headquarters from Houston to Dubai. Better oil exploration and production opportunities, they say. That Dubai has some of the world's most liberal tax and investment laws probably doesn't hurt either.
Hilary Wicai | Mar 12, 2007
The nation's largest independent sub-prime lender may be the latest victim of the housing slowdown. New Century Financial says the banks that keep its money flowing are cutting the lifelines.
John Dimsdale | Mar 12, 2007
Latest emergency spending bill: The White House wants another $100 billion to pay for the wars in Iraq and Afghanistan, and Democrats have attached additional dollars for domestic items. But somebody's gotta lose. . .
Stephen Beard and Scott Jagow | Mar 12, 2007
The E.U. is poised to slash sugar subsidies — a move that could ruin producers in Africa and the Caribbean. So Barbados is hoping to find a high-end market for its ultra-sweet, ultra-expensive sugar.
Stephen Beard | Mar 12, 2007
The dark cloud of insider trading was cast over a $19 billion bid for Britain's largest pharmacy chain, Boots, last week. Inconvenient timing for regulators who'd just announced that 25% of London deals are preceded by suspicious trading activity.